Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic and immunologic features of recurrent stage I lung adenocarcinoma.

Scientific reports - 8 Dec 2021

Kratz Johannes R, Li Jack Z, Tsui Jessica, Lee Jen C, Ding Vivianne W, Rao Arjun A, Mann Michael J, Chan Vincent, Combes Alexis J, Krummel Matthew F, Jablons David M

Abstract excerpt

Although surgery for early-stage lung cancer offers the best chance of cure, recurrence still occurs between 30 and 50% of the time. Why patients frequently recur after complete resection of early-stage lung cancer remains unclear. Using a large cohort of stage I lung adenocarcinoma patients, distinct genetic, genomic, epigenetic, and immunologic profiles of recurrent tumors were analyzed using a novel recurrence...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma of Lung
Share to Computational Biology

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Susceptibility

Share to Epigenesis, Genetic

Share to Neoplasm Recurrence, Local

Share to Neoplasm Staging

Share to Proportional Hazards Models

Share to Tumor Microenvironment

Source

Open in PubMed Open full text

Identifiers

PMID: 34880292
DOI: 10.1038/s41598-021-02946-0
PMCID: PMC8654957

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic and immunologic features of recurrent stage I lung adenocarcinoma.PMID 34880292Read ↗

Multiomic Characterization of Stage I Lung Adenocarcinoma Reveals Distinct Genetic and Immunologic Features of Recurrent DiseaseSemantic proximity Read ↗

Multi-omics analyses reveal biological and clinical insights in recurrent stage I non-small cell lung cancerSemantic proximity Read ↗

Spatiotemporal genomic analysis reveals distinct molecular features in recurrent stage I non-small cell lung cancers.Semantic proximity Read ↗

Integrative bulk, single-cell and spatial transcriptomics characterizes the immune context of proliferative recurrence risk in early lung adenocarcinomaSemantic proximity Read ↗

Genomic profiling implicates candidate genes and mutagenic pathways driving lung cancer recurrenceSemantic proximity Read ↗

Recurrence-associated gene signature in patients with stage I non-small-cell lung cancer.Semantic proximity Read ↗

Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinomaSemantic proximity Read ↗

Multi‑omics analysis identifies different molecular subtypes with unique outcomes in early-stage poorly differentiated lung adenocarcinomaSemantic proximity Read ↗

Targeted Next-Generation Sequencing Analysis for Recurrence in Early-Stage Lung Adenocarcinoma.Semantic proximity Read ↗

Association of oropharyngeal cancer recurrence with tumor-intrinsic and immune-mediated sequelae of reduced genomic instabilitySemantic proximity Read ↗

Molecular architecture of the tumor microenvironment caused by <i>BRCA1</i> and <i>BRCA2</i> somatic mutations in lung adenocarcinomaSemantic proximity Read ↗

DNA Methylation Profiling Identifies Subgroups of Lung Adenocarcinoma with Distinct Immune Cell Composition, DNA Methylation Age, and Clinical Outcome.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.